205
Views
2
CrossRef citations to date
0
Altmetric
Research Article

The role of urinary KIM-1, NGAL, CA19-9 and β2-microglobulin in the assessment of ureteropelvic junction obstruction in adults

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 682-688 | Received 29 Oct 2016, Accepted 06 Jan 2017, Published online: 08 Feb 2017

References

  • Aybek, H., et al., 2006. Elevation of serum and urinary carbohydrate antigen 19-9 in benign hydronephrosis. International journal of urology, 13, 1380–1384.
  • Bartoli, F., et al., 2011. Urinary epidermal growth factor, monocyte chemotactic protein-1, and β2-microglobulin in children with ureteropelvic junction obstruction. Journal of pediatric surgery, 46, 530–536.
  • Castagnetti, M., et al., 2008. Scintigraphic renal function after unilateral pyeloplasty in children: a systematic review. BJU international, 102, 862–868.
  • Caubet, C., et al., 2010. Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease. Pediatric nephrology, 25, 27–35.
  • Chertin, B., et al., 2002. Does delaying pyeloplasty affect renal function in children with a prenatal diagnosis of pelvi-ureteric junction obstruction? *BJU international, 90, 72–75.
  • Chevalier, R.L., 2004. Biomarkers of congenital obstructive nephropathy: past, present and future. Journal of urology, 172, 852–857.
  • Cost, N.G., et al., 2013. Urinary NGAL levels correlate with differential renal function in patients with ureteropelvic junction obstruction undergoing pyeloplasty. Journal of urology, 190, 1462–1467.
  • Decramer, S., Bascands, J.L., and Schanstra, J.P., 2007. Non-invasive markers of ureteropelvic junction obstruction. World journal of urology, 25, 457–465.
  • El-Sherbiny, M.T., et al., 2002. Role of urinary transforming growth factor-beta1 concentration in the diagnosis of upper urinary tract obstruction in children. Journal of urology, 168, 1798–1800.
  • Endre, Z.H. and Westhuyzen, J., 2008. Early detection of acute kidney injury: emerging new biomarkers. Nephrology (Carlton), 13, 91–98.
  • Grandaliano, G., et al., 2000. MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy. Kidney international, 58, 182–192.
  • Kajbafzadeh, A.M., et al., 2010. Urinary and serum carbohydrate antigen 19-9 as a biomarker in ureteropelvic junction obstruction in children. Journal of urology, 183, 2353–2360.
  • Kausik, S. and Segura, J.W., 2003. Surgical management of ureteropelvic junction obstruction in adults. International Brazilian journal of urology, 29, 3–10.
  • Khan, F., et al., 2014. Management of ureteropelvic junction obstruction in adults. Nature reviews urology, 11, 629–638.
  • Lam, J.S., Breda, A., and Schulam, P.G., 2007. Ureteropelvic junction obstruction. Journal of urology, 177, 1652–1658.
  • Lam, W., et al., 2015. Is routine postoperative diuresis renography indicated in all adult patients after pyeloplasty for ureteropelvic junction obstruction? Urology, 85, 246–251.
  • Lucarelli, G., et al., 2014. Emerging urinary markers of renal injury in obstructive nephropathy. BioMed research international, 2014, 303298.
  • Madsen, M.G., et al., 2011. Urinary biomarkers in prenatally diagnosed unilateral hydronephrosis. Journal of pediatric urology, 7, 105–112.
  • Madsen, M.G., et al., 2012a. Epidermal growth factor and monocyte chemotactic peptide-1: potential biomarkers of urinary tract obstruction in children with hydronephrosis. Journal of pediatric urology, 9, 838–845
  • Madsen, M.G., et al., 2012b. Urinary NGAL, cystatin C, β2-microglobulin, and osteopontin significance in hydronephrotic children. Pediatric nephrology, 27, 2099–2106.
  • Mesrobian, H.G.O. and Mirza, S.P., 2012. Hydronephrosis: a view from the inside. Pediatric clinics of North America, 59, 839–851.
  • Papachristou, F., Pavlaki, A., and Printza, N., 2014. Urinary and serum biomarkers in ureteropelvic junction obstruction: a systematic review. Biomarkers, 19, 531–540.
  • Park, J.M. and Bloom, D.A., 1998. The pathophysiology of UPJ obstruction. Current concepts. The urologic clinics of North America, 25, 161–169.
  • Taha, M.A., et al., 2007a. Diagnosis of ureteropelvic junction obstruction in children: role of endothelin-1 in voided urine. Urology, 69, 560–564. discussion 564-565.
  • Taha, M.A., et al., 2007b. Obstructed versus dilated nonobstructed kidneys in children with congenital ureteropelvic junction narrowing: role of urinary tubular enzymes. Journal of urology, 178, 640–646.
  • Taha, M.A., et al., 2007c. Pelvi-ureteric junction obstruction in children: the role of urinary transforming growth factor-beta and epidermal growth factor. BJU international, 99, 899–903.
  • Tapia, J. and Gonzalez, R., 1995. Pyeloplasty improves renal function and somatic growth in children with ureteropelvic junction obstruction. Journal of urology, 154, 218–222.
  • Wasilewska, A., et al., 2011. KIM-1 and NGAL: new markers of obstructive nephropathy. Pediatric nephrology, 26, 579–586.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.